Page last updated: 2024-10-25

debrisoquin and Neoplasms, Otorhinolaryngologic

debrisoquin has been researched along with Neoplasms, Otorhinolaryngologic in 1 studies

Debrisoquin: An adrenergic neuron-blocking drug similar in effects to GUANETHIDINE. It is also noteworthy in being a substrate for a polymorphic cytochrome P-450 enzyme. Persons with certain isoforms of this enzyme are unable to properly metabolize this and many other clinically important drugs. They are commonly referred to as having a debrisoquin 4-hydroxylase polymorphism.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Other Studies

1 other study available for debrisoquin and Neoplasms, Otorhinolaryngologic

ArticleYear
[Oncologic and related topics].
    Archives of oto-rhino-laryngology. Supplement = Archiv fur Ohren-, Nasen- und Kehlkopfheilkunde. Supplement, 1985, Volume: 2

    Topics: Antibodies, Monoclonal; Antibody Specificity; Antineoplastic Agents; Combined Modality Therapy; Debr

1985